Patrick O’Brien
Investor Relations Contact chez PARDES BIOSCIENCES, INC.
Profil
Patrick O’Brien currently works at Pardes Biosciences, Inc., as Senior Vice President-Investor Relations.
Mr. O’Brien also formerly worked at Gilead Sciences, Inc., as Vice President-Investor Relations, Ligand Pharmaceuticals, Inc., as Investor Relations Contact, and Vir Biotechnology, Inc., as Investor Relations Contact.
Mr. O’Brien received his undergraduate degree from Loyola University New Orleans and Masters Business Admin degree from Kellogg School of Management.
Postes actifs de Patrick O’Brien
| Sociétés | Poste | Début |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Investor Relations Contact | - |
Anciens postes connus de Patrick O’Brien
| Sociétés | Poste | Fin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Investor Relations Contact | - |
| GILEAD SCIENCES, INC. | Investor Relations Contact | - |
| LIGAND PHARMACEUTICALS INCORPORATED | Public Communications Contact | - |
Formation de Patrick O’Brien
| Loyola University New Orleans | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
